Gabriele Facchini

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Gabriele Facchini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Article

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial
Caffo, O., Ortega, C., Nolè, F., Gasparro, D., Mucciarini, C., Aieta, M., Zagonel, V., Iacovelli, R., De Giorgi, U., Facchini, G., Veccia, A., Palesandro, E., Verri, E., Buti, S., Razzini, G., Bozza, G., Maruzzo, M., Ciccarese, C., Schepisi, G., Rossetti, S., & 20 othersMaines, F., Fratino, L., Ermacora, P., Nicodemo, M., Giordano, M., Sartori, D., Scapoli, D., Sabbatini, R., Lo Re, G., Morelli, F., D'Angelo, A., Vittimberga, I., Lippe, P., Carrozza, F., Messina, C., Galli, L., Valcamonico, F., Porta, C., Pappagallo, G. & Aglietta, M., 2021, In: European Journal of Cancer. 155, p. 56-63 8 p.
Research output: Contribution to journal › Article › peer-review

Gabriele Facchini

Fingerprint

Research output

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial